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The Problem Areas in Diabetes (PAID) scale is a widely used self-report measure that can facilitate detection of diabetes-specific
emotional distress in clinical practice. The aim of this study was to assess the factor structure and validity of the Turkish version
of the PAID. A validation study was conducted among 154 patients with insulin-naı̈ve type 2 diabetes. Participants completed the
PAID, Centre for Epidemiological Studies Depression Scale (CES-D), Insulin Treatment Appraisal Scale (ITAS), and World Health
Organization-Five Well-Being Index (WHO-5) questionnaires. Exploratory factor analyses yielded a 2-factor structure, identifying
a 15-item “diabetes distress” factor and a 5-item “support-related issues” factor. The total PAID-score and the two dimensions were
associated with higher levels of depression and poor emotional well-being. In the present study, the Turkish version of the PAID
had satisfactory psychometric properties, however, the factorial structure was found to differ from factor solutions from other
countries.
1. Introduction
Type 2 diabetes is an increasingly common, often burden-
some illness. People living with type 2 diabetes not only have
a chronic condition to cope with, but they are also faced with
the presence and/or the prospect of serious complications
[1]. The fact that living with diabetes often confronts patients
with diabetes-specific stressors may explain the recent find-
ings of Ali et al. [2], who found that depression is up to four
times more likely in patients with type 2 diabetes compared
to a general population. In depressed diabetes patients, in-
creased levels of diabetes-specific emotional distress were
found [3, 4]. Furthermore, diabetes-specific stressors were
found to be associated with less adequate self-care and im-
paired glycemic control [5, 6]. However, the recognition
rates of high levels of diabetes-specific emotional distress
appeared to be low [7]. Therefore, it seems important
that diabetes health care providers and diabetes researchers
have access to instruments that can assess disease-specific
emotional distress in a valid and reliable way. One widely
used instrument is the Problem Areas in Diabetes (PAID)
scale. The PAID is a 20-item self-report survey that assesses
a range of emotional problems related to having type 1 or
type 2 diabetes. Previous research has shown that the PAID is
a clinically relevant and psychometrically sound instrument
[8, 9]. Higher PAID scores were associated with lower
levels of adherence to treatment and with higher levels of
depression and HBA1c [10, 11].
The PAID has been translated into several languages and
has been validated in Hispanic [1], Dutch, American [8],
Chinese [12], Brazilian [13], Swedish [14], Icelandic [15],
African American [1, 16] samples. Recently, a 5-item version
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and a 1-item version of the PAID have been developed [17].
However, because the factor structure of the PAID seems to
differ across cultures, further translation and cross-cultural
validation of the PAID is needed. In 2002, the prevalence of
diabetes in Turkey was estimated at 2.6 million. The aim of
the present study is therefore to validate the Turkish version
of the PAID and make this instrument available for use in
Turkish diabetes research and clinical practices.
2. Participants and Methods
The study was conducted in two outpatient clinics in
Istanbul, Turkey: the Istanbul Medical Faculty Hospital and
the Cerrahpaşa Medical Faculty Hospital, as described by
Makine et al. [18]. A total number of 220 patients with type
2 diabetes mellitus who were treated with diet and/or oral
agents were invited to participate in the study. Exclusion cri-
teria for this study were being illiterate or not being able to
read due to vision problems. All participants gave written
informed consent, and the Ethical Review Committee of the
Istanbul University Medical Faculty and Cerrahpaşa Medical
Faculty approved the study [18].
Table 1 shows the sample characteristics of the final 154
participants, separately for the two clinics. Mean age was 56
± 10 years, mean duration of diabetes was 7 ± 6.5 years, and
mean HbA1c was 6.6 ± 1.0%.
2.1. Measures. Information was collected on age, sex, marital
status, income, education, height, weight, time of diabetes
onset, diabetes treatment, complications, and HbA1c lev-
els. Medical and psychological treatments and history of
depression were collected using self-report. As a measure of
concurrent validity of the PAID, patients were asked to rate
their perception of the difficulty of regulating their diabetes
(metabolic control) on a scale from 1 (not difficult) to 4 (very
difficult). The Turkish versions of all measures were used.
2.1.1. Diabetes-Specific Emotional Distress (PAID). The Prob-
lem Areas in Diabetes (PAID) scale is a self-report measure
with 20 items and was translated by Makine et al. [18].
The items contain statements regarding four domains of
quality of life with respect to diabetes (emotional distress,
treatment issues, food-related problems, and lack of social
support) and are rated on a scale from 0 (not a problem) to
4 (a serious problem). Scores on the PAID are summed and
transformed to a 0–100 scale, with higher scores indicating
greater emotional distress [8–11].
2.1.2. Depression (CES-D). The Centre for Epidemiological
Studies Depression Scale (CES-D; [19, 20]) was used to assess
the occurrence of depressive symptoms in the last week. The
CES-D contains 20 items that are rated on a scale from 0
(rarely or never/less than one day) to 3 (most or all the
time/5 to 7 days). CES-D scores are summed, with higher
scores indicating more depressive symptoms. The internal
consistency in this sample was 0.88.
2.1.3. Insulin Treatment Appraisal Scale (ITAS). The Insulin
Treatment Appraisal Scale (ITAS; [18]) was used to assess
attitudes towards insulin treatment [21]. The ITAS contains
20 items that are scored on a scale from 1 (strongly disagree)
to 5 (strongly agree). The scores are summed, with a higher
score indicating a more negative attitude towards insulin
therapy. The internal consistency in this sample was 0.82.
2.1.4. WHO-5. The World Health Organization-Five Well-
Being Index (WHO-5; [22]) was used to assess general emo-
tional well-being. The WHO-5 is a short 5-item measure,
rated on a scale from 0 (not at all) to 5 (constantly) how
often they have felt in a certain way in the last two weeks. The
scores are summed and transformed to a 0–100 scale, with
higher scores indicating better emotional well-being. The
WHO-5 has an internal consistency of 0.87 in this sample.
2.2. Statistical Analysis. SPSS version 17 for Windows was
used to carry out statistical analyses. Associations between
categorical variables were analysed using nonparametric tests
and continuous variables with t-tests. The Eigenvalue > 1
criterion and inspection of the scree plot [23] were used to
determine the optimal number of factors. To assess the factor
structure of the Turkish version of the PAID, exploratory fac-
tor analysis with oblimin rotation was used, as we assumed
the factors to be correlated. Cronbach’s α was calculated as a
measure of internal consistency. To measure concurrent and
convergent validity, Pearson product moment correlations,
or χ2 for dichotomous variables, were calculated.
3. Results
3.1. Demographic Indices. Patients from the two clinics did
not differ with regard to age, gender, diabetes duration,
or treatment. However, the Cerrahpaşa University Hospital
had a higher prevalence of depression (CES-D ≥ 16) than
the Istanbul University Clinic (19% versus 32%, ρ < 0.05).
Furthermore, depression appeared to be more common in
women than in men with type 2 diabetes. Moreover, women
had a significantly lower education level than men.
Diabetes was treated with diet for 22.7% of the partic-
ipants, 74,7% of the participants received oral medication
and 2,6% of the participants did not receive any treatment
yet. Mean value for the Turkish PAID was 27 ± 19.
3.2. Factor Analysis. Using the Kaiser criterion (Eigenvalues
> 1), a 1-, 2- or 3-factor solution could be calculated, but
as a Dutch-US validation study found four dimensions, we
also calculated the 4-factor solution (Table 2). The three-
and four-factor solutions resulted in factors with low and
double factor loadings. Interestingly, the two-factor solution
resulted in a clear 15-item “diabetes distress” factor and
a 5-item “support-related issues” factor. The eigenvalue of
the diabetes distress factor was 10.4 (explaining 52% of the
variance) and the eigenvalue of the support-related issues
factor was 1.3 (explaining a further 6.7% of the variance
before rotation). The item “feelings of deprivation regarding
food” had the highest loading on the diabetes distress factor,
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Table 1: Demographic, clinical, and psychological characteristics of male and female participants with type 2 diabetes, who were treated in
the outpatient clinic of the Istanbul University Hospital or the Cerrahpaşa University Hospital.
Istanbul University Hospital Cerrahpaşa University Hospital
Male Female Male Female
% (n) 48% (47) 52% (51) 41% (23) 59% (33)
Age (years) 56 ± 10 55 ± 9 60 ± 13 56 ± 9
BMI 27 ± 3 30 ± 5 29 ± 4 31 ± 6
HbA1c (mmol/mol) 6.8 ± 1.2 (51) 6.6 ± 0.9 (49) 6.3 ± 0.9 (45) 6.6 ± 0.9 (49)
Duration of diabetes (years)
<1 9% (4/47) 2% (1/51) 26% (6/23) 15% (5/33)
1-2 15% (7/47) 16% (8/51) 9% (2/23) 15% (5/33)
3-4 15% (7/47) 20% (10/51) 13% (3/23) 15% (5/33)
5–10 38% (18/47) 41% (21/51) 35% (8/23) 30% (10/33)
>10 23% (11/47) 22% (11/51) 17% (4/23) 24% (8/33)
Level of education ∗ ∗
Primary school 2% (1/47) 28% (14/51) 9% (2/23) 46% (15/33)
Middle school 15% (7/47) 6% (3/51) 13% (3/23) 24% (8/33)
College/High school 34% (16/47) 24% (12/51) 30% (7/23) 9% (3/33)
University 49% (23/47) 43% (22/51) 48% (11/23) 21% (7/33)
Diabetes complications
No complication 60% (28/47) 63% (32/51) 70% (16/23) 64% (21/33)
Retinopathy 9% (4/47) 4% (2/51) 0% (0/23) 6% (2/33)
Cardiovascular 15% (7/47) 14% (7/51) 17% (4/23) 6% (2/33)
Nephropathy 2% (1/47) 6% (3/51) 0% (0/23) 6% (2/33)
Neuropathy 23% (11/47) 24% (12/51) 13% (3/23) 21% (7/33)
Foot problem 13% (6/47) 8% (4.51) 4% (1/23) 9% (3/33)
Mean CES-D score (depression) 9.7 ± 7.8 11.6 ± 8.9 7.3 ± 8.1 14.3 ± 13.0
High level of depression (CES-D ≥ 16) 13% (6/46) 24% (12/49) 22% (5/23) 40% (13/33)
Mean PAID total score (0–100) 28 ± 23 34 ± 22 30 ± 23 39 ± 24
Mean ITAS total score 52 ± 10 56 ± 9 54 ± 9 53 ± 13
∗
P ≤ 0.01, comparing men and women within the same hospital.
and the item “feeling alone with your diabetes” loaded the
highest on the support-related issues factor. The internal
consistency of the PAID and the two factors were Cronbach’s
α = 0.85 for the support-related issues factor, Cronbach’s α =
0.94 for the diabetes distress factor, and Cronbach’s α = 0.95
for the total 20-item PAID.
3.3. Convergent Validity. Table 3 shows the correlations
between total 20-item PAID, the two factors and other meas-
ures of interest. Also, correlations with the scores on the
shorter versions of the PAID, the PAID-1, and PAID-5 are
shown as suggested by McGuire et al. [17]. Higher scores on
the total PAID and its subscales scores were significantly asso-
ciated with higher levels of depression (CES-D) scores and
a more negative appraisal of insulin therapy (ITAS scores),
and also with higher ratings of having problems with the
regulation of blood glucose levels. Negative associations were
found with WHO-5 scores. Furthermore, older people had
lower PAID scores. Additionally, the PAID scores appeared
not to be associated with HbA1c levels or the number of years
since diagnosis. The results were comparable for the PAID-1
and PAID-5.
Female participants had significantly higher total PAID
scores than males (30 ± 19 versus 23 ± 19; ρ < 0.05),
and women also scored slightly higher on both the diabetes
distress factor (25 ± 15 versus 20 ± 15, ρ < 0.05) and
support-related issues factor (5 ± 5 versus 3 ± 5, ρ <
0.05). Furthermore, a significant association with education
was found: participants who attended primary school versus
patients that attended college/high school reported higher
levels of diabetes-specific emotional distress on the total
PAID (35 ± 19 versus 22 ± 17, ρ < 0.05) and on the support-
related issues factor (5 ± 5 versus 2 ± 3, ρ < 0.05).
Moreover, patients who reported having complications
(n = 57) scored significantly higher on the PAID total
(31 ± 17 versus 24 ± 19, P < 0.05) and on the diabetes
distress factor (27 ± 14 versus 20 ± 16, ρ < 0.05) than
patients without complications. Also, patients with a history
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Table 2: 1-, 2-, 3-, and 4-factor solution after exploratory factor analysis of the 20 PAID items.
Factor solution
Shortened item content 1F 2F 3F 4F
F1 F2 F1 F2 F3 F1 F2 F3 F4
Feeling overwhelmed by your
diabetes?
.87 .82 .73 .73
Feeling discouraged with
treatment plan?
.72 .56 .50 .34 .56
Feeling scared? .82 .85 .74 .68
Uncomfortable social situations? .68 .86 .92 .89
Feelings of deprivation regarding
food?
.73 .89 .77 .82
Feeling depressed? .82 .88 .78 .75
Feeling angry? .85 .81 .74 .73
Concerned about food and
eating?
.81 .76 .70 .71
Not “accepting” your diabetes? .66 .50 .59 .44 .45
Mood related to your diabetes? .80 .71 .41 .42 .40 .38
Not having clear and concrete
goals?
.5 .54 .67 .61 .51
Worrying about low blood sugar
reactions?
.68 .60 .62 .59
Coping with complications? .70 .50 .51 .48
Worrying about complications? .70 .67 .85 .80
Feelings of guilt or anxiety? .68 .54 .78 .74
Unsatisfied with diabetes
physician?
.53 .69 .65 .65
Diabetes is taking up too much
energy?
.73 .74 .73 .75
Feeling alone with your diabetes? .73 .79 .81 .83
Feeling that others are not
supportive?
.54 .75 .72 .75
Feeling “burned out”? .76 .67 .66 .69
Eigenvalue before rotation 10.4 10.4 1.3 10.4 1.3 1.2 10.4 1.3 1.2 0.9
% variance before rotation 52.1 52.1 6.7 52.1 6.7 6.2 52.1 6.7 6.2 4.5
Eigenvalue after rotation 9.9 7.0 8.9 6.6 6.8 8.6 6.9 5.9 2.0
Cronbach’s α .95 .94 .85 .94 .85 .86 .94 .85 .86 .67
Table 3: Correlations between total PAID, the two factors, the PAID-1 and PAID-5, and other measures of interest.
CES-D ITAS WHO-5 Age HbA1c Diabetes Duration Regulation Difficulty†
PAID total .447∗∗ .390∗∗ −.472∗∗ −.347∗∗ .092 −.125 273.96∗∗
PAID factor 1
Diabetes distress
.412∗∗ .367∗∗ −.444∗∗ −.348∗∗ .083 −.126 258.17∗∗
PAID factor 2
Support-related issues
.463∗∗ .375∗∗ −.454∗∗ −.266∗∗ .099 −.092 215.22∗∗
PAID-1
“Worrying about the future
and the possibility of serious
complications”
.348∗∗ .247∗∗ −.309∗∗ −.234∗∗ .062 −.098 22.82∗
PAID-5
PAID items 3,6,12,16,19
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of depression treatment had significantly higher scores of
diabetes distress (31 ± 14 versus 20 ± 15, ρ < 0.01), support-
related issues (6 ± 6 versus 4 ± 4, ρ < 0.01), and total PAID
scores (37 ± 18 versus 24 ± 17, ρ < 0.01).
4. Discussion
The aim of this study was to assess the psychometric prop-
erties of the Turkish version of the PAID. Exploratory factor
analysis clearly yielded a solution with one general 20-
item factor or two separate factors: “diabetes distress” and
“support-related issues”. This is only partially consistent with
findings from other studies that assessed the cross-cultural
validity of the PAID. Factor analyses of the Swedish version
of the PAID [14], consisting of 20 items, found a similar
structure although with a three-factor solution: diabetes-
related emotional problems, treatment-related problems,
and also a support-related problems scale. Also, even though
the factor solution in an Icelandic sample [15] resulted
in two similarly named factors: “distress in relation to life
with diabetes” and “distress in relation to management of
diabetes”, they are not comparable to the factors found in this
study.
In Dutch and US diabetes patients however, Snoek et
al. [8] reported that both a one- and a four-factor solution
(emotional, treatment, food, and lack of support problems)
fitted well. Also, the Chinese version consisted of only
one factor [12]. In short, even though the twenty item
scales are comparable between countries, the subscales are
not. Consequently, the comparability of study results from
different countries is perhaps rather low in case subscales are
being used.
The Turkish version of the PAID and its two factors
appeared to be internally consistent. As expected, the PAID
and the two factors were strongly associated with generic
measures of affect. Higher levels of diabetes distress were as-
sociated with a higher frequency of depressive symptoms
occurrence, negative attitudes toward insulin treatment, dif-
ficulties with the regulation of the blood glucose, and
lower levels of emotional well-being. Additionally, patients
who reported having diabetes complications or a history of
depression treatment scored significantly higher on the
PAID, indicative of discriminative validity. Furthermore,
PAID scores were unrelated to the number of years since di-
agnosis. Unexpectedly, and incongruent with other studies,
the PAID was not related to HbA1c levels [8, 10, 11, 14,
15]. However, the patients included in the sample were
insulin naı̈ve and well controlled with respect to HbA1c. The
absence of poorly controlled patients in the present sample
may thus explain why diabetes-specific emotional distress
was not associated with glycemic control. A non significant
association between PAID and HbA1c was also found in a
Brazilian sample (n = 146) [13] and two African American
samples (n = 109 and n = 131) [1, 16]. These non significant
associations may be explained by the small samples sizes of
these studies. Additionally, an unexpected effect of education
level on PAID scores was found, inconsistent with other
studies [8–11] but in concurrence with some other studies
[1, 13, 15]. The relationship between higher education
and lower PAID scores may be explained by an increased
understanding of HbA1c knowledge, diabetes control, and
diabetes care for patients with higher education [24].
Other studies have found a distress factor similar to
the one in the current study. Interestingly, “worry about
the future and the possibility of serious complications” was
consistently found to be the emotional problem with the
highest factor loading [8, 10, 11, 14, 16] whereas in the
present study “feelings of deprivation regarding food” was
the item with the highest loading. Furthermore, where a spe-
cial “food-related problems” factor was found in the Dutch
and US sample [8], in the current study, the items regarding
food did not form a separate factor but instead were strongly
integrated in the diabetes distress factor. These findings
suggest cross-cultural differences in diabetes-related distress.
Where in countries such as the Netherlands and the United
States food issues are seen as related to diabetes but separate
from social problems [8], it may be that in countries such
as Turkey food is an integral and important factor of social
life. A limitation of the study was that the sample was too
small to allow confirmatory factor analysis, which could have
provided with confirmatory evidence of the factor solution
found in the current study. Furthermore, the test-retest re-
liability of the Turkish version was not assessed.
In conclusion, the Turkish version of the PAID showed
good internal consistency, discriminative, and convergent
validity, but appeared to have a different factor structure than
other versions. For international comparisons, use of the 20-
item overall factor solution is recommended.
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